Literature DB >> 30354400

The American Heart Association Heart Failure Summit, Bethesda, April 12, 2017.

Pamela N Peterson1,2, Larry A Allen1, Paul A Heidenreich3,4, Nancy M Albert5, Ileana L Piña6.   

Abstract

The American Heart Association convened a meeting to summarize the changing landscape of heart failure (HF), anticipate upcoming challenges and opportunities to achieve coordinated identification and treatment, and to recommend areas in need of focused efforts. The conference involved representatives from clinical care organizations, governmental agencies, researchers, patient advocacy groups, and public and private healthcare partners, demonstrating the breadth of stakeholders interested in improving care and outcomes for patients with HF. The main purposes of this meeting were to foster dialog and brainstorm actions to close gaps in identifying people with or at risk for HF and reduce HF-related morbidity, mortality, and hospitalizations. This report highlights the key topics covered during the meeting, including (1) identification of patients with or at risk for HF, (2) tracking patients once diagnosed, (3) application of population health approaches to HF, (4) improved strategies for reducing HF hospitalization (not just rehospitalization), and (5) promoting HF self-management.

Entities:  

Keywords:  heart failure; humans; morbidity; population health; quality of health care

Mesh:

Year:  2018        PMID: 30354400      PMCID: PMC6211812          DOI: 10.1161/CIRCHEARTFAILURE.118.004957

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  40 in total

1.  Prevention of "Failure": Is It a Failure of Prevention?

Authors:  Vijay Nambi; Anita Deswal; Christie M Ballantyne
Journal:  Circulation       Date:  2018-01-09       Impact factor: 29.690

2.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Relationships between emerging measures of heart failure processes of care and clinical outcomes.

Authors:  Adrian F Hernandez; Bradley G Hammill; Eric D Peterson; Clyde W Yancy; Kevin A Schulman; Lesley H Curtis; Gregg C Fonarow
Journal:  Am Heart J       Date:  2010-03       Impact factor: 4.749

Review 4.  Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review.

Authors:  Ana C Alba; Thomas Agoritsas; Milosz Jankowski; Delphine Courvoisier; Stephen D Walter; Gordon H Guyatt; Heather J Ross
Journal:  Circ Heart Fail       Date:  2013-07-25       Impact factor: 8.790

5.  Risk-Adjusted In-Hospital Mortality Models for Congestive Heart Failure and Acute Myocardial Infarction: Value of Clinical Laboratory Data and Race/Ethnicity.

Authors:  Eunjung Lim; Yongjun Cheng; Christine Reuschel; Omar Mbowe; Hyeong Jun Ahn; Deborah T Juarez; Jill Miyamura; Todd B Seto; John J Chen
Journal:  Health Serv Res       Date:  2015-06-15       Impact factor: 3.402

6.  Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).

Authors:  Michel Komajda; Peter E Carson; Scott Hetzel; Robert McKelvie; John McMurray; Agata Ptaszynska; Michael R Zile; David Demets; Barry M Massie
Journal:  Circ Heart Fail       Date:  2010-11-10       Impact factor: 8.790

7.  The Situation-Specific Theory of Heart Failure Self-Care: Revised and Updated.

Authors:  Barbara Riegel; Victoria Vaughan Dickson; Kenneth M Faulkner
Journal:  J Cardiovasc Nurs       Date:  2016 May-Jun       Impact factor: 2.083

8.  Patient activation and 30-day post-discharge hospital utilization.

Authors:  Suzanne E Mitchell; Paula M Gardiner; Ekaterina Sadikova; Jessica M Martin; Brian W Jack; Judith H Hibbard; Michael K Paasche-Orlow
Journal:  J Gen Intern Med       Date:  2013-10-04       Impact factor: 5.128

9.  Recent national trends in readmission rates after heart failure hospitalization.

Authors:  Joseph S Ross; Jersey Chen; Zhenqiu Lin; Héctor Bueno; Jeptha P Curtis; Patricia S Keenan; Sharon-Lise T Normand; Geoffrey Schreiner; John A Spertus; Maria T Vidán; Yongfei Wang; Yun Wang; Harlan M Krumholz
Journal:  Circ Heart Fail       Date:  2009-11-10       Impact factor: 8.790

10.  Evaluation of the appropriateness of the preclinical phase (stage A and stage B) of heart failure Management in Outpatient clinics in Italy rationale and design of the 'VASTISSIMO' study.

Authors:  Gian F Mureddu; Stefano Nistri; Pompilio Faggiano; Biagio Fimiani; Gianfranco Misuraca; Antonio Maggi; Anna M Gori; Massimo Uguccioni; Luigi Tavazzi; Giovanni B Zito
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2016-07       Impact factor: 2.160

View more
  3 in total

1.  Determination of optimal implantation site in central venous system for wireless hemodynamic monitoring.

Authors:  Tejaswini Manavi; Patricia Vazquez; Muhammad Tubassam; Junaid Zafar; Faisal Sharif; Haroon Zafar
Journal:  Int J Cardiol Heart Vasc       Date:  2020-04-03

2.  A novel wireless implant for central venous pressure measurement: First animal experience.

Authors:  Tejaswini Manavi; Patricia Vazquez; Helen O'Grady; Jerson Martina; Michael Rose; Douglas Nielsen; David Fitzpatrick; Omid Forouzan; Michael Nagy; Faisal Sharif; Haroon Zafar
Journal:  Cardiovasc Digit Health J       Date:  2020-10-29

3.  Age and gender differences in diagnostic decision-making of early heart failure: results of a mixed-methods interview-study using video vignettes.

Authors:  Gabriella Marx; Sarah Koens; Olaf von dem Knesebeck; Martin Scherer
Journal:  BMJ Open       Date:  2022-03-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.